Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 121Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


CARdiovascular Outcome study of LINAgliptin versus glimepiride in patients with T2D trial

Nath Baishali, Suvarna Viraj Ramesh

Year : 2020| Volume: 11| Issue : 1 | Page no: 44-46

   This article has been cited by
1 Role of Gliclazide in Safely Navigating Type 2 Diabetes Mellitus Patients Towards Euglycemia: Expert opinion from India
Subhash Wangnoo,M. Shunmugavelu,Sagili Vijaya Bhaskar Reddy,Vijay Negalur,Shreerang Godbole,Vinay K Dhandhania,Nareen Krishna,Kumar Gaurav
Endocrine and Metabolic Science. 2021; : 100102
[Pubmed]  [Google Scholar] [DOI]
2 The efficacy and safety of Dipeptyl Peptidase-4 inhibitors compared to other Oral glucose-lowering medications in the treatment of type 2 diabetes
Anca Pantea Stoian,Alexandros Sachinidis,Roxana Adriana Stoica,Dragana Nikolic,Angelo Maria Patti,Ali A. Rizvi
Metabolism. 2020; : 154295
[Pubmed]  [Google Scholar] [DOI]


Read this article